Also trades as: GMRE-PA (NYSE) · $vol 0M
GMRE NYSE
Global Medical REIT Inc.
1W: +0.0%
1M: -2.5%
3M: +11.8%
YTD: +5.6%
1Y: -10.8%
3Y: -4.0%
5Y: -20.3%
$35.74
Last traded 2026-03-09 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$148M
+7.1% ▲
5Y CAGR: +9.6%
Gross Profit
$0
-100.0% ▼
Operating Income
$0
-100.0% ▼
Net Income
-$12M
-282.7% ▼
EPS (Diluted)
$-0.91
-393.5% ▼
EBITDA
$78M
-15.1% ▼
5Y CAGR: +7.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $116M | $137M | $141M | $138M | $148M |
| YoY Growth | +23.8% | +18.4% | +2.7% | -1.8% | +7.1% |
| Cost of Revenue | $15M | $25M | $28M | $29M | $0 |
| Gross Profit | $100M | $112M | $113M | $109M | $0 |
| Gross Margin | 86.6% | 81.6% | 80.1% | 78.9% | 0.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16M | $17M | $17M | $21M | $20M |
| Operating Expenses | $63M | $73M | $75M | $76M | $148M |
| Operating Income | $37M | $39M | $38M | $33M | $0 |
| Operating Margin | 31.9% | 28.2% | 26.9% | 23.6% | 0.0% |
| Interest Expense | $20M | $25M | $31M | $29M | $32M |
| Income Before Tax | $18M | $20M | $22M | $7M | -$12M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $18M | $19M | $21M | $7M | -$12M |
| Net Margin | 15.2% | 14.0% | 14.6% | 4.8% | -8.2% |
| EPS (Diluted) | $-0.85 | $-2.00 | $5.75 | $0.31 | $-0.91 |
| EBITDA | $85M | $103M | $112M | $91M | $78M |
| Shares Outstanding | 2M | 3M | 3M | 3M | 13M |